Canadian Analytical Laboratories is authorized by Health Canada to provide analytical testing services for Psilocybin and Psilocin.
Canadian Analytical Laboratories is a leader in Method Development and Method Validation. We work with selected partners for the quantification of psilocybin and psilocin in mushroom matrices that have been compounded into different pharmaceutical dosage forms.
Psilocybin and Psilocin are psychoactive or hallucinogenic indole alkaloids produced by numerous mushroom species that are also commonly referred to as “magic mushrooms”. Both substances are controlled under the Controlled Drugs and Substances Act (CDSA).
Our laboratory is Canadian Drug GMP compliant and offers a range of expert analytical and regulatory solutions to support product quality and product development activities through our Rapid Method Development, Method Validation, Stability Studies, and Quality Control Testing capabilities.
Our robust investment program into modern technologies and analytical instrumentation assures not only a broad service profile but a refinement of existing technologies to assure accuracy and precision of the assays we execute. Our expert teams coupled with our investments in analytical instrumentation are predicated on the execution of our laboratory services in a fully GMP compliant manner. Learn more about our Pharmaceutical analytical testing capabilities.